P revention encompasses measures to protect healthy individuals from developing a medical condition or to mitigate the progression of an illness (1) . Prevention can play an important role in the public health management of acute medical conditions. For example, myocardial infarction and stroke were once believed to be untreatable conditions triggered by acute exposures (e.g., stress or exercise) or random processes (2, 3) . However, the recognition of heart disease and stroke as endpoints of a chronic disease process allowed for a paradigm shift from acute care to the management of a chronic disease process. The identification of treatable risk factors has led to the broad application of risk stratification, detection, and reduction strategies, contributing to a more than 70% decline in heart disease and stroke mortality, a feat declared as one the 10 greatest public health achievements of the last century (4).
Sepsis is a major public health problem associated with over 750,000 hospital admissions, 570,000 emergency department visits, 200,000 deaths, and $16.7 billion in medical expenditures in the United States annually (5) (6) (7) (8) . Much like myocardial infarction and stroke in the distant past, current thinking has conceptualized sepsis primarily as an acute event, with attention focused on its early identification and resuscitation (9, 10) . However, as with other acute conditions, chronic processes such as chronic lung disease, chronic kidney disease, and obesity are known to contribute to the long-term likelihood of sepsis (11, 12) . Although counter to current acute care paradigms, the understanding of an individual's baseline susceptibility could present important opportunities to reduce the long-term risk and societal burden of sepsis in the general population.
Important steps in disease prevention include not only the identification of individual risk factors but also the characterization of a person's cumulative risk. A population-based cohort offers the optimal design for these goals, linking baseline individual characteristics with events identified over an extended follow-up period. The 30,239-subject REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort is one of the largest longitudinal population-based cohorts in the United States (13) . In prior studies, we have identified a range of sociodemographic factors, modifiable health behaviors, preventable and treatable chronic medical conditions, and biomarkers independently associated with sepsis events occurring over a 10-year follow-up period (11, 12, 14) . In the current study, we sought to derive and internally validate a Sepsis Risk Score (SRS) and a Severe Sepsis Risk Score (SSRS) characterizing community-dwelling individuals' long-term risks of sepsis and severe sepsis. Although designed to characterize U.S. geographic and racial disparities in stroke mortality, REGARDS is comprised of community-dwelling adults at a stable phase of health-not just individuals suffering from a stroke (13) . The REGARDS design includes oversampling of individuals from the Southeastern United States, with 21% of the cohort originating from the coastal plains of North Carolina, South Carolina, and Georgia (the "stroke buckle"), and 35% from the remainder of North Carolina, South Carolina, and Georgia plus Tennessee, Mississippi, Alabama, Louisiana, and Arkansas (the "stroke belt"). Among REGARDS participants, 42% are African American, 45% are men, and 69% are 60 years old or older.
MATERIALS AND METHODS
Enrollment of REGARDS participants occurred between 2003 and 2007, with ascertainment of baseline participant information including medical history, functional status, health behaviors, physical characteristics (height and weight), physiologic measures (blood pressure, pulse, and electrocardiogram), current medications, diet, family history of diseases, psychosocial factors, and prior residences. The study also collected blood and urine specimens from each participant. REGARDS contacted study participants by telephone at 6-month intervals to identify the date, location, and attributed reason for all hospitalizations.
Identification of Sepsis and Severe Sepsis Hospitalization Events
Using the taxonomy of Angus et al (6), we identified emergency department visits or hospital admissions attributed by participants to a serious infection. Two trained abstractors independently reviewed relevant medical records to identify clinical and laboratory information, confirm the presence of a serious infection on initial hospital presentation, and to verify the relevance of the serious infection as a major reason for hospitalization. We included hospitalization events for February 5, 2003 , to December 31, 2012. Sepsis events consisted of presentation to the hospital with a serious infection plus two or more systemic inflammatory response syndrome (SIRS) criteria (5) . Severe sepsis events consisted of the presence of sepsis plus at least one organ dysfunction (defined by the Sequential Organ Dysfunction Assessment for respiratory, renal, hepatic, cardiovascular, hematologic, and neurologic systems) or hypotension (systolic blood pressure ≤ 90 mm Hg) (15) . We defined SIRS, organ dysfunction, and hypotension using any asynchronous combination of the most abnormal vital signs and laboratory test values observed during the initial 28 hours of hospitalization, allowing for emergency department and up to one full day of inpatient treatment. Because of our focus on community-acquired rather than hospital-acquired sepsis, we did not use clinical data from later points of hospitalization (16) .
connections with future sepsis events (11, 12, 14, 17) . Participant demographic characteristics included age, sex, race, geographic region, annual household income, and education (years of school). We dichotomized age at 75 years because of a higher sepsis risk observed at this threshold. Health behaviors included smoking status and alcohol use. Chronic medical conditions included atrial fibrillation, chronic lung disease, coronary artery disease, diabetes, deep vein thrombosis, dyslipidemia, hypertension, myocardial infarction, obesity, peripheral artery disease, and stroke (for detailed definitions, see Appendix 1, Supplemental Digital Content 1, http://links.lww. com/CCM/B725).
We also considered select biomarkers that could be broadly measured in community-dwelling individuals, were available in the REGARDS cohort, and exhibited plausible connections with future sepsis risk. Because prior studies have associated chronic kidney disease with sepsis risk, we evaluated estimated glomerular filtration rate (eGFR) based upon serum creatinine as well as urinary albumin-to-creatinine ratio (ACR) (11, 18, 19) . Because of its association with long-term sepsis risk independent of eGFR and ACR, we assessed serum cystatin C (cyst-C) (17) . We also considered high-sensitivity C-reactive protein (hsCRP), which has been associated with long-term sepsis risk (20) . (for detailed definitions, see Appendix 1, Supplemental Digital Content 1, http://links.lww.com/CCM/B725).
Data Analysis
Although the primary objective of the study was to develop a sepsis risk prediction model (SRS), current clinical initiatives often focus on the identification of severe sepsis (9) . Therefore, we developed a parallel but separate prediction model for severe sepsis (SSRS). We followed identical analytic strategies for derivation and internal validation of the SRS and SSRS.
We limited the analyses to first-sepsis and first-severe sepsis events. Using Pearson's chi-square test, we compared characteristics between participants who did and did not experience sepsis or severe sepsis events. To identify SRS and SSRS risk factors, we fit a series of multivariable Cox regression models, defining elapsed time as the period from subject enrollment to the first sepsis or first severe sepsis event. Participants not experiencing a sepsis or severe sepsis event were censored on death or at the point of last follow-up (December 31, 2012).
A traditional approach to prediction rule development is split-sample derivation and validation (e.g., derivation using half of the dataset, validation using the other half), but this approach reduces the available analytic data and may result in overly pessimistic model performance estimates (21) . Therefore, we opted to derive the SRS and SSRS using the entire cohort, assessing discrimination using bootstrap resampling (22) . This approach has been shown to provide greater efficiency than traditional split-sample validation (21) .
Because of a substantial number of missing values for select covariates (cyst-C, 6.8%; hsCRP, 6.4%; ACR, 4.7%; eGFR, 4.5%), we also performed the analyses using multiple imputation (23, 24) . We performed multiple imputation using chained equations with the Stata "MI" suite, generating 10 imputed datasets and pooling estimates using Rubin's rules (25) . For prognostic measures involving resampling techniques (e.g., concordance statistics and reclassification indices), we determined the median, minimum, and maximum values across imputations (25) .
For each imputed dataset, we first fit a model (model 1) using backward elimination of participant demographics, health behaviors, and chronic medical conditions. We used p value of less than or equal to 0.1 as a criterion for retention. We then fit a model adding the variables elevated hsCRP, elevated cyst-C, elevated ACR, and decreased eGFR (model 2), reflecting a clinical scenario with the availability of select biomarkers measurements. We did not include participant income, education, or region in the models because it was unclear how these variables would be used in clinical practice. We followed the same variable selection and model development strategies for the SRS and SSRS.
Our a priori plan was to select models within each imputation (26) . As identical SRS and SSRS models resulted from each imputation, methods for handling differences in variable selection across imputations were not required. We developed point systems for each model by standardizing beta coefficients for each factor to the lowest coefficient, summing the integer point values, and averaging the points across imputations (27) . For each model, we separated participants into five-graded risk score categories.
For the regression model and point system of each SRS and SSRS model, we assessed discrimination using an optimismadjusted concordance statistic (Harrell's C Index), estimated using bootstrap resampling with 150 replicates (transformed Dxy obtained from validation in the R package "RMS") (22) . We assessed model fit and calibration using the Groennesby and Borgan score test (Stata "stcoxgof " command) (28) . We also assessed calibration by plotting the observed and expected prevalence rates by PI deciles. To assess the improvements in discrimination between SRS models 1 and 2 and SSRS models 1 and 2, we used an extension of the Net Reclassification Improvement (NRI) index to survival data (1/2NRI(> 0) from R package survIDINRI), estimating NRI using 200 resamplingperturbations and assessing the values at the midpoint of the observation period (5 yr) (29, 30) .
We used Stata 12.1 (Stata, College Station, TX) and R 3.1.1 (R Foundation for Statistical Computing, Vienna, Austria) for all analyses.
RESULTS
The median observation period among REGARDS participants was 6.6 years (interquartile range [IQR], 5.1-8.1). There were 1,532 first sepsis (prevalence, 8.3 per 1,000 person-years; 95% CI, 7.9-8.7) and 1,151 first severe sepsis (prevalence, 6.2 per 1,000 person-years; 95% CI, 5.8-6.5) events. Median elapsed times to first sepsis and severe sepsis events were 3.7 years (IQR, 1.8-5.6 yr) and 3.8 years (IQR, 2.0-5.7 yr), respectively. The most common infections associated with first sepsis and first severe sepsis events were pneumonia, kidney and urinary tract infections, and abdominal infections ( first sepsis cases fulfilled severe sepsis criteria. ICU admission and hospital and 30-day mortality were higher for first severe sepsis than for first sepsis cases.
When compared with other REGARDS participants, individuals experiencing a sepsis event were older, more likely to be men and white, and more likely to report lower education and annual income ( Table 2) . Although sepsis participants were more likely to report prior or current tobacco use, they were less likely to report moderate or heavy alcohol use. Chronic medical conditions were more common in sepsis participants. Sepsis participants were more likely to have abnormal hsCRP, cyst-C, eGFR, and ACR. Similar associations were observed with participants experiencing a severe sepsis event.
SRS model 1 contained 13 independent predictors, of which chronic lung disease and age 75 years old or older were the most influential variables ( Table 3) . In addition to incorporating the biomarkers (abnormal hsCRP, cyst-C, ACR, and eGFR), SRS model 2 also retained all model 1 predictors. Chronic lung disease, age 75 years old or older, peripheral artery disease, elevated hsCRP, elevated cyst-C, and elevated ACR were the most influential SRS model 2 variables.
We partitioned each SRS model into five-graded risk categories (very low, low, medium, high, and very high) ( Table 4 and SSRS model 1 contained the same 13 independent predictors as SRS model 1 (Table 3 ). In addition to incorporating the biomarkers (abnormal hsCRP, cyst-C, ACR, and eGFR), SSRS model 2 also retained all model 1 predictors. Compared with SSRS model 1, SSRS model 2 exhibited the best combination of model fit and discrimination (Table 4 and 
DISCUSSION
Current scientific and clinical initiatives conceptualize sepsis as an acute condition (31) . However, as with other acute conditions such as myocardial infarction and stroke, immense public health gains could be appreciated if sepsis were recognized as the preventable end result of a chronic disease process (32) . Important steps in disease prevention include not only the identification of individual factors associated with the condition but also the development of strategies to characterize individuals' cumulative risk. We previously identified a range of individual factors associated with future sepsis events (11, 12, 17) . The current analysis provides important and novel advancements, offering risk prediction tools characterizing an individual's 10-year risk of sepsis and severe sepsis based upon their pattern of comorbidities. There have been no prior similar efforts to estimate or characterize long-term sepsis risk in this fashion. Our study sets the stage for risk prediction and prevention as potential strategies to reduce the public health burden of sepsis. The clinical application of the SRS and SSRS is in contexts that may not be familiar to critical and acute care practitioners. These risk scores are potentially useful for outpatients to prevent or mitigate the early effects of sepsis. For example, knowledge of an individual's baseline sepsis risk may impact outpatient or early hospital care of infections, prompting earlier antibiotic therapy, or inpatient rather than outpatient treatment. Key elements in the SRS and SSRS, such as chronic lung disease, peripheral artery disease, tobacco use, coronary artery disease, obesity, hypertension, deep vein thrombosis, and chronic kidney disease, can be modified or optimally managed. Should a novel therapy prove effective at sepsis prevention, the SRS and SSRS could be used to select high risk individuals most likely to benefit from the intervention. For example, hsCRP has been used to identify high cardiovascular risk individuals most likely to benefit from statin therapy (33) .
Our derivation of separate sepsis and severe sepsis risk prediction models illustrates the robustness of the models as well as the potential choices influencing clinical implementation. Some may favor the SRSS because of its higher discrimination and focus on predicting higher acuity severe sepsis events. However, the predictors of the SRS and SSRS were nearly identical; this observation is not surprising as 70% of sepsis events fulfilled severe sepsis criteria. Also, we used clinical data limited to the first 28 hours of hospitalization, (34) (35) (36) . However, these decision rules are designed for inpatients, focusing upon the outcomes of those already afflicted by sepsis. Our SRS and SSRS offer a very different outpatient application, identifying the long-term risk of sepsis and severe sepsis among community-dwelling adults at a stable phase of health, prior to the onset of disease.
Naturally, additional efforts are needed prior to SRS or SSRS implementation in clinical practice, including validation with an independent dataset. However, the current risk scores are highly feasible and could be easily implemented in outpatient settings. Although not currently in broad clinical practice, outpatient measurements of hsCRP and cyst-C (key components of SRS model 2 and SSRS model 2) are attainable. The conceptual frameworks of the SRS and SSRS allow for incorporation of additional participant factors or biomarkers to improve risk prediction. For example, in a nested case-control series we have linked markers of endothelial cell activation and inflammation with increased odds of sepsis (37) .
REGARDS is not a surveillance study and may have underidentified sepsis events. REGARDS included only African Americans and whites 45 years old or older. REGARDS did not include nursing home patients, who may be more vulnerable to sepsis than community-dwelling individuals. We did not have information on the presence of select immunosuppressive comorbidities such as human immunodeficiency virus infection or liver disease. We opted not to incorporate information on the use of immunosuppressive medications such as corticosteroids and rheumatologic agents because the use of such medications in REGARDS is low (< 3%). Although we used biomarkers that were readily available, other biomarkers may have potentially improved model discrimination. We could not account for changes in participants characteristics over time.
Our analysis consisted entirely of medical record-verified community-acquired sepsis and severe sepsis. We are currently linking REGARDS participants to their corresponding Medicare claims, which may allow identification of hospitalacquired or healthcare-associated sepsis (16) .
Whereas we derived the risk prediction models using Cox regression, other techniques are possible (e.g., Classification and Regression Tree analysis) (38) . We note that the current SRS and SSRS exhibited calibration and discrimination comparable with other commonly used clinical risk prediction models (39) . Although we conceptualized the SRS and SSRS as having roles in primary prevention, further study is also needed to confirm whether risk modification in fact leads to reduced sepsis risk.
CONCLUSIONS
We derived a SRS and a SSRS that accurately predict 10-year risks of sepsis and severe sepsis among community-dwelling adults. The SRS and SSRS may play key roles in community sepsis prevention or mitigation efforts. 
